BDBM359621 N-((1-Aminoisoquinolin-6-yl)methyl)-5-(hydroxy(4-((4-methyl-1H-pyrazol-1-yl)methyl)phenyl)methyl)nicotinamide::US10221161, Example 7::US11242333, Example 7

SMILES Cc1cnn(Cc2ccc(cc2)C(O)c2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)c1

InChI Key InChIKey=LJHHAYREDCAYJE-UHFFFAOYSA-N

Data  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 359621   

TargetPlasma kallikrein(Homo sapiens (Human))
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM359621(N-((1-Aminoisoquinolin-6-yl)methyl)-5-(hydroxy(4-(...)
Affinity DataIC50:  35.3nMAssay Description:Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetKallikrein-1(Homo sapiens (Human))
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM359621(N-((1-Aminoisoquinolin-6-yl)methyl)-5-(hydroxy(4-(...)
Affinity DataIC50:  8.02E+3nMAssay Description:KLK1 inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM359621(N-((1-Aminoisoquinolin-6-yl)methyl)-5-(hydroxy(4-(...)
Affinity DataIC50:  35.3nMAssay Description:Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetKallikrein-1(Homo sapiens (Human))
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM359621(N-((1-Aminoisoquinolin-6-yl)methyl)-5-(hydroxy(4-(...)
Affinity DataIC50:  8.02E+3nMAssay Description:KLK1 inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent